References
- Adcock DM, Hicks MJ. Dermatopathology of skin necrosis associated with purpura fulminans. Semin Thromb Hemost. 1990;16:283–292.
- Levin M, Eley BS, Louis J, et al. Post infectious purpura fulminans caused by an autoantibody directed against protein S. J Pediatr. 1995;127:355–363.
- Poort SR, et al. A common genetic variation in the 3'-untranslated region of prothrombin gene in association with elevated plasma prothrombin level and an increase in venous thrombosis Blood. 1996;88:3698.
- Francis RB. Acquired purpura fulminans. Semin Thromb Hemost. 1990;16:310–325.
- Hjort PF, Rapaport SI, Jorgensen L. Purpura fulminans: report of a case successfully treated with heparin and hydrocortisone: review of 50 cases literature. Scand J Haematol. 1964;1: 169–192.
- Wong UK, Hitchcock W, Manson HW. Meningococcal infections in children: a review of 100 cases. Pediatr Infect ThsJ 1989;8: 224–227.
- Marlar RA, Neumann A. Neonatal purpura fulminans due to homozygous protein C or protein S deficiencies. Semin Thromb Haemost. 1990;16:229–309.
- Rosendaal FR, et al. Geographic distribution of the 20210G to A pro thrombin variant. Thromb Haemost. 1998;79:706.
- Rosendaal FR. Risk factors for venous thrombois; prevalence, risk and interaction. Semin Hematol. 1997;34:171.
- Martinelli l, SacchiE,Landi G, et al. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med. 1998;338:1793–1797.